FGL2 and hepatocellular carcinoma: To investigate the role of sFGL2 in HCC progression, the growth of BNL or Hepa1–6 cells was evaluated in subcutaneous murine HCC models in Fgl2−/− mice or treated with the anti-FGL2 antibody in WT mice with a BALB/c or C57BL/6 background.